stockportfolio.pro
Inspire Medical Systems, Inc. (INSP)
Healthcare · Medical Devices · NYSE
Inspire Medical Systems, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.43M | $28.57M | $50.59M | $82.05M | $115.38M | $233.39M | $407.86M | $624.80M | $802.80M | $911.98M |
| Gross profit | $12.52M | $22.55M | $40.54M | $68.41M | $97.76M | $200.12M | $341.74M | $528.22M | $679.82M | $778.76M |
| Net income | $-18.53M | $-17.51M | $-21.83M | $-33.24M | $-57.20M | $-42.04M | $-44.88M | $-21.15M | $53.51M | $145.42M |
| Net margin | -112.8% | -61.3% | -43.1% | -40.5% | -49.6% | -18.0% | -11.0% | -3.4% | 6.7% | 15.9% |
Source: Inspire Medical Systems, Inc. SEC filings (10-K).
Explore 10 years of Inspire Medical Systems, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track INSP in your portfolio →
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems, Inc. — frequently asked questions
What is Inspire Medical Systems, Inc.'s revenue?
Inspire Medical Systems, Inc. (INSP) reported revenue of $911.98M for fiscal year 2025, up 13.6% from the prior year, according to its SEC filings.
Is Inspire Medical Systems, Inc. profitable?
Yes. INSP earned net income of $145.42M in fiscal 2025, a net margin of 15.9%.
What is INSP's P/E ratio?
Inspire Medical Systems, Inc. trades at a price-to-earnings ratio of about 9.6 based on the latest data in our nightly-refreshed cache.
How fast is Inspire Medical Systems, Inc. growing?
INSP's revenue grew at roughly 51.2% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
Where does this data come from?
All figures are computed from Inspire Medical Systems, Inc.'s official SEC filings (10-K and 10-Q), covering 10 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.